These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25909088)

  • 41. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
    Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
    Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The relationship between glucocerebrosidase mutations and Parkinson disease.
    Migdalska-Richards A; Schapira AH
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):77-90. PubMed ID: 26860875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Presenting symptoms of GBA-related Parkinson's disease.
    Kresojević N; Janković M; Petrović I; Kumar KR; Dragašević N; Dobričić V; Novaković I; Svetel M; Klein C; Pekmezović T; Kostić VS
    Parkinsonism Relat Disord; 2015 Jul; 21(7):804-7. PubMed ID: 25957717
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gene-wise association of variants in four lysosomal storage disorder genes in neuropathologically confirmed Lewy body disease.
    Clark LN; Chan R; Cheng R; Liu X; Park N; Parmalee N; Kisselev S; Cortes E; Torres PA; Pastores GM; Vonsattel JP; Alcalay R; Marder K; Honig LL; Fahn S; Mayeux R; Shelanski M; Di Paolo G; Lee JH
    PLoS One; 2015; 10(5):e0125204. PubMed ID: 25933391
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lysosomes to combat Parkinson's disease.
    Isacson O
    Nat Neurosci; 2015 Jun; 18(6):792-3. PubMed ID: 26007211
    [No Abstract]   [Full Text] [Related]  

  • 46. Role of LIMP-2 in the intracellular trafficking of β-glucosidase in different human cellular models.
    Malini E; Zampieri S; Deganuto M; Romanello M; Sechi A; Bembi B; Dardis A
    FASEB J; 2015 Sep; 29(9):3839-52. PubMed ID: 26018676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. No evidence for substrate accumulation in Parkinson brains with GBA mutations.
    Gegg ME; Sweet L; Wang BH; Shihabuddin LS; Sardi SP; Schapira AH
    Mov Disord; 2015 Jul; 30(8):1085-9. PubMed ID: 26096906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological Chaperones and Coenzyme Q10 Treatment Improves Mutant β-Glucocerebrosidase Activity and Mitochondrial Function in Neuronopathic Forms of Gaucher Disease.
    de la Mata M; Cotán D; Oropesa-Ávila M; Garrido-Maraver J; Cordero MD; Villanueva Paz M; Delgado Pavón A; Alcocer-Gómez E; de Lavera I; Ybot-González P; Paula Zaderenko A; Ortiz Mellet C; García Fernández JM; Sánchez-Alcázar JA
    Sci Rep; 2015 Jun; 5():10903. PubMed ID: 26045184
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The emergence of Parkinson disease among patients with Gaucher disease.
    Elstein D; Alcalay R; Zimran A
    Best Pract Res Clin Endocrinol Metab; 2015 Mar; 29(2):249-59. PubMed ID: 25987177
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease.
    Taguchi YV; Liu J; Ruan J; Pacheco J; Zhang X; Abbasi J; Keutzer J; Mistry PK; Chandra SS
    J Neurosci; 2017 Oct; 37(40):9617-9631. PubMed ID: 28847804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dopaminergic control of autophagic-lysosomal function implicates Lmx1b in Parkinson's disease.
    Laguna A; Schintu N; Nobre A; Alvarsson A; Volakakis N; Jacobsen JK; Gómez-Galán M; Sopova E; Joodmardi E; Yoshitake T; Deng Q; Kehr J; Ericson J; Svenningsson P; Shupliakov O; Perlmann T
    Nat Neurosci; 2015 Jun; 18(6):826-35. PubMed ID: 25915474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. GBA1 deficiency negatively affects physiological α-synuclein tetramers and related multimers.
    Kim S; Yun SP; Lee S; Umanah GE; Bandaru VVR; Yin X; Rhee P; Karuppagounder SS; Kwon SH; Lee H; Mao X; Kim D; Pandey A; Lee G; Dawson VL; Dawson TM; Ko HS
    Proc Natl Acad Sci U S A; 2018 Jan; 115(4):798-803. PubMed ID: 29311330
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Drosophila Model of Neuronopathic Gaucher Disease Demonstrates Lysosomal-Autophagic Defects and Altered mTOR Signalling and Is Functionally Rescued by Rapamycin.
    Kinghorn KJ; Grönke S; Castillo-Quan JI; Woodling NS; Li L; Sirka E; Gegg M; Mills K; Hardy J; Bjedov I; Partridge L
    J Neurosci; 2016 Nov; 36(46):11654-11670. PubMed ID: 27852774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glucocerebrosidase Deficiency in Drosophila Results in α-Synuclein-Independent Protein Aggregation and Neurodegeneration.
    Davis MY; Trinh K; Thomas RE; Yu S; Germanos AA; Whitley BN; Sardi SP; Montine TJ; Pallanck LJ
    PLoS Genet; 2016 Mar; 12(3):e1005944. PubMed ID: 27019408
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutations in the glucocerebrosidase gene are common in patients with Parkinson's disease from Eastern Canada.
    Han F; Grimes DA; Li F; Wang T; Yu Z; Song N; Wu S; Racacho L; Bulman DE
    Int J Neurosci; 2016; 126(5):415-21. PubMed ID: 26000814
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glucocerebrosidase deficiency and mitochondrial impairment in experimental Parkinson disease.
    Noelker C; Lu L; Höllerhage M; Vulinovic F; Sturn A; Roscher R; Höglinger GU; Hirsch EC; Oertel WH; Alvarez-Fischer D; Andreas H
    J Neurol Sci; 2015 Sep; 356(1-2):129-36. PubMed ID: 26104567
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The G2019S LRRK2 mutation increases myeloid cell chemotactic responses and enhances LRRK2 binding to actin-regulatory proteins.
    Moehle MS; Daher JP; Hull TD; Boddu R; Abdelmotilib HA; Mobley J; Kannarkat GT; Tansey MG; West AB
    Hum Mol Genet; 2015 Aug; 24(15):4250-67. PubMed ID: 25926623
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gaucher disease: a lysosomal neurodegenerative disorder.
    Huang WJ; Zhang X; Chen WW
    Eur Rev Med Pharmacol Sci; 2015 Apr; 19(7):1219-26. PubMed ID: 25912581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A new role for α-synuclein in Parkinson's disease: Alteration of ER-mitochondrial communication.
    Guardia-Laguarta C; Area-Gomez E; Schon EA; Przedborski S
    Mov Disord; 2015 Jul; 30(8):1026-33. PubMed ID: 25952565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?
    Zaltieri M; Longhena F; Pizzi M; Missale C; Spano P; Bellucci A
    Parkinsons Dis; 2015; 2015():108029. PubMed ID: 25918668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.